The Valve Trials Are Done: Interventional HFpEF Is the Next Big Thing

Northwestern Medicine Bluhm Cardiovascular Institute

S. Shah

Heart Failure with Preserved Ejection Fraction: Current Perspectives…

American College of Cardiology

S. Shah

Medical Management of Diastolic Dysfunction: Does The Emperor Finall…

Top Ten Topics in Clinical Cardiology 2023

S. Pinney

How to Detect and Treat Heart Failure with Preserved Ejection Fracti…

Houston Methodist DeBakey Heart and Vascular Center

Extended Anticoagulation for VTE

Jeffrey Weitz

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

American Heart & Vascular Institute

M. Kittleson

ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…

American Heart & Vascular Institute

B. Reddy

Heart Failure with Preserved Ejection Fraction: New Treatments

Scripps Health

R. C. Mohan

Diabetes and Heart Failure: The New Frontier

Mount Sinai Advanced Innovations in Heart Failure Symposium 2019

E. Braunwald

The CCM Solution: How Does it Work and What Does it Do?

CCM® Therapy

N. Varma

The ISCHEMIA Trial: Are There Differences in Primary and Secondary O…

Mount Sinai

G. Stone

Right Ventricular Failure: Diagnosis and Management

Scripps Health: 2019 Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

A. Srivastava

'Heart Failure: Future perspectives

Arun Kochar

A. Kochar